BCL2 and cancer: In their landmark publications, Hanahan and Weinberg identified resistance to cell death as a defining feature, a so-called hallmark, of cancer and suggest the use of BH3 mimetics which target members of the Bcl-2 family to overcome this resistance [9,10].